Authors:
Pittaluga, A
Feligioni, M
Ghersi, C
Gemignani, A
Raiteri, M
Citation: A. Pittaluga et al., Potentiation of NMDA receptor function through somatostatin release: a possible mechanism for the cognition-enhancing activity of GABA(B) receptor antagonists, NEUROPHARM, 41(3), 2001, pp. 301-310
Authors:
Pittaluga, A
Pattarini, R
Feligioni, M
Raiteri, M
Citation: A. Pittaluga et al., N-methyl-D-aspartate receptors mediating hippocampal noradrenaline and striatal dopamine release display differential sensitivity to quinolinic acid,the HIV-1 envelope protein gp120, external pH and protein kinase C inhibition, J NEUROCHEM, 76(1), 2001, pp. 139-148
Authors:
Gemignani, A
Paudice, P
Pittaluga, A
Raiteri, M
Citation: A. Gemignani et al., The HIV-1 coat protein gp120 and some of its fragments potently activate native cerebral NMDA receptors mediating neuropeptide release, EUR J NEURO, 12(8), 2000, pp. 2839-2846
Citation: A. Pittaluga et al., Somatostatin potentiates NMDA receptor function via activation of InsP(3) receptors and PKC leading to removal of the Mg2+ block without depolarization, BR J PHARM, 130(3), 2000, pp. 557-566
Authors:
Pittaluga, A
Bonfanti, A
Arvigo, D
Raiteri, M
Citation: A. Pittaluga et al., Aniracetam, 1-BCP and cyclothiazide differentially modulate the function of NMDA and AMPA receptors mediating enhancement of noradrenaline release inrat hippocampal slices, N-S ARCH PH, 359(4), 1999, pp. 272-279
Authors:
Pittaluga, A
Pattarini, R
Andrioli, GC
Viola, C
Munari, C
Raiteri, M
Citation: A. Pittaluga et al., Activity of putative cognition enhancers in kynurenate test performed withhuman neocortex slices, J PHARM EXP, 290(1), 1999, pp. 423-428